2019
DOI: 10.1038/s10038-019-0682-5
|View full text |Cite
|
Sign up to set email alerts
|

Alazami syndrome: the first case of papillary thyroid carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
27
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 13 publications
(29 citation statements)
references
References 28 publications
2
27
0
Order By: Relevance
“…Of the 14 identified variants, 12 were frameshift, one was nonsense, and one was predicted to cause abnormal splicing. Therefore, all deleterious variants causing Alazami syndrome are presumably null alleles [5]. Our findings are in line with the current literature, as the variant detected in our patient is a frameshift predicted to cause the deletion of the last 217 amino acids and, therefore, the loss of the RNA recognition motif 2 (RRM2).…”
Section: Discussionsupporting
confidence: 92%
See 2 more Smart Citations
“…Of the 14 identified variants, 12 were frameshift, one was nonsense, and one was predicted to cause abnormal splicing. Therefore, all deleterious variants causing Alazami syndrome are presumably null alleles [5]. Our findings are in line with the current literature, as the variant detected in our patient is a frameshift predicted to cause the deletion of the last 217 amino acids and, therefore, the loss of the RNA recognition motif 2 (RRM2).…”
Section: Discussionsupporting
confidence: 92%
“…To date, the clinical effect of deleterious variants in LARP7 is restricted to Alazami syndrome. Currently, 24 patients from 12 families are described as having Alazami syndrome and recessive variants in LARP7 [5]. Of the 14 identified variants, 12 were frameshift, one was nonsense, and one was predicted to cause abnormal splicing.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Noteworthy, based on clinical findings and presence of peculiar malformations, a diagnosis of SLOS was originally suspected in our siblings ( Table 1). The SLOS phenotypic spectrum is very broad, ranging from a mild disorder with subtle facial dysmorphisms and behavioral and/or learning problems to a prenatally lethal condition (Bianconi et al, 2015;Nowaczyk & Wassif, 1993-2020. Syndactyly of the second and third toes is the most frequent clinical finding in patients with SLOS: its association with growth failure, intellectual disability with autistic traits, and a spectrum of malformations often including corpus callosum and septum pellucidum anomalies, congenital heart defects, and hypospadias should prompt testing for this condition (Lee, Conley, Gropman, Porter, & Baker, 2013;Nowaczyk & Irons, 2012;Porter, 2008).…”
Section: Discussionmentioning
confidence: 99%
“…To date, 24 affected patients, belonging to 12 families, have been reported, all sharing a core of recognizable features: (a) short stature bordering in some cases with primordial dwarfism; (b) moderate to severe global developmental delay/intellectual disability (GDD/ID); (c) peculiar dysmorphisms, including prominent forehead, deep‐set eyes, malar hypoplasia, broad nose, wide mouth, and widely spaced teeth. Other findings such as microcephaly, congenital heart defects, and autistic/maladaptive behaviors have been reported in about half cases (Alazami et al, 2012; Dateki et al, 2018; Elmas et al, 2019; Hollink et al, 2016; Holohan et al, 2016; Imbert‐Bouteille et al, 2019; Ivanovski et al, 2020; Karaca et al, 2015; Ling & Sorrentino, 2016; Najmabadi et al, 2011; Wojcik, Linnea, Stoler, & Rappaport, 2019).…”
Section: Introductionmentioning
confidence: 99%